_version_ 1785090460502458368
author Lee, Hans C.
Bumma, Naresh
Richter, Joshua
Dhodapkar, Madhav
Hoffman, James E.
Suvannasankha, Attaya
Zonder, Jeffrey
Shah, Mansi R.
Lentzsch, Suzanne
Maly, Joseph J.
Ye, Jing Christine
Wu, Ka Lung
Deveaux, Michelle
Chokshi, Dhruti
Boyapati, Anita
Hazra, Anasuya
Lorenc, Karen Rodriguez
Kroog, Glenn
Houvras, Yariv
Jagannath, Sundar
author_facet Lee, Hans C.
Bumma, Naresh
Richter, Joshua
Dhodapkar, Madhav
Hoffman, James E.
Suvannasankha, Attaya
Zonder, Jeffrey
Shah, Mansi R.
Lentzsch, Suzanne
Maly, Joseph J.
Ye, Jing Christine
Wu, Ka Lung
Deveaux, Michelle
Chokshi, Dhruti
Boyapati, Anita
Hazra, Anasuya
Lorenc, Karen Rodriguez
Kroog, Glenn
Houvras, Yariv
Jagannath, Sundar
author_sort Lee, Hans C.
collection PubMed
description
format Online
Article
Text
id pubmed-10428402
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104284022023-08-17 S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA Lee, Hans C. Bumma, Naresh Richter, Joshua Dhodapkar, Madhav Hoffman, James E. Suvannasankha, Attaya Zonder, Jeffrey Shah, Mansi R. Lentzsch, Suzanne Maly, Joseph J. Ye, Jing Christine Wu, Ka Lung Deveaux, Michelle Chokshi, Dhruti Boyapati, Anita Hazra, Anasuya Lorenc, Karen Rodriguez Kroog, Glenn Houvras, Yariv Jagannath, Sundar Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428402/ http://dx.doi.org/10.1097/01.HS9.0000967700.16100.68 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Sessions
Lee, Hans C.
Bumma, Naresh
Richter, Joshua
Dhodapkar, Madhav
Hoffman, James E.
Suvannasankha, Attaya
Zonder, Jeffrey
Shah, Mansi R.
Lentzsch, Suzanne
Maly, Joseph J.
Ye, Jing Christine
Wu, Ka Lung
Deveaux, Michelle
Chokshi, Dhruti
Boyapati, Anita
Hazra, Anasuya
Lorenc, Karen Rodriguez
Kroog, Glenn
Houvras, Yariv
Jagannath, Sundar
S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
title S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_full S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_fullStr S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_full_unstemmed S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_short S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_sort s197: linker-mm1 study: linvoseltamab (regn5458) in patients with relapsed/refractory multiple myeloma
topic Oral Sessions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428402/
http://dx.doi.org/10.1097/01.HS9.0000967700.16100.68
work_keys_str_mv AT leehansc s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT bummanaresh s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT richterjoshua s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT dhodapkarmadhav s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT hoffmanjamese s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT suvannasankhaattaya s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT zonderjeffrey s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT shahmansir s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT lentzschsuzanne s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT malyjosephj s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT yejingchristine s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT wukalung s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT deveauxmichelle s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT chokshidhruti s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT boyapatianita s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT hazraanasuya s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT lorenckarenrodriguez s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT kroogglenn s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT houvrasyariv s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT jagannathsundar s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma